Diamant M - Search Results

1

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.

Diamant M, Heine RJ. Diamant M, et al. Drugs. 2003;63(13):1373-405. doi: 10.2165/00003495-200363130-00004. Drugs. 2003. PMID: 12825962 Review.

2

Nonalcoholic fatty liver disease and cardiovascular disease risk.

Schindhelm RK, Diamant M, Heine RJ. Schindhelm RK, et al. Among authors: diamant m. Curr Diab Rep. 2007 Jun;7(3):181-7. doi: 10.1007/s11892-007-0030-6. Curr Diab Rep. 2007. PMID: 17547835 Free article. Review.

3

Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus.

Schindhelm RK, Alssema M, Diamant M, Teerlink T, Dekker JM, Kok A, Kostense PJ, Nijpels G, Heine RJ, Scheffer PG. Schindhelm RK, et al. Among authors: diamant m. Metabolism. 2008 Feb;57(2):262-7. doi: 10.1016/j.metabol.2007.09.010. Metabolism. 2008. PMID: 18191058

4

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M. van der Meer RW, et al. Among authors: diamant m. Circulation. 2009 Apr 21;119(15):2069-77. doi: 10.1161/CIRCULATIONAHA.108.803916. Epub 2009 Apr 6. Circulation. 2009. PMID: 19349323 Free article. Clinical Trial.

5

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.

Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Schindhelm RK, et al. Among authors: diamant m. Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):437-43. doi: 10.1002/dmrr.666. Diabetes Metab Res Rev. 2006. PMID: 16832839 Review.

6

Incretin mimetics as a novel therapeutic option for hepatic steatosis.

Tushuizen ME, Bunck MC, Pouwels PJ, van Waesberghe JH, Diamant M, Heine RJ. Tushuizen ME, et al. Among authors: diamant m. Liver Int. 2006 Oct;26(8):1015-7. doi: 10.1111/j.1478-3231.2006.01315.x. Liver Int. 2006. PMID: 16953843

7

[Metabolic syndrome: limited significance for clinical practice].

Dekker JM, Diamant M, Nijpels G, Heine RJ. Dekker JM, et al. Among authors: diamant m. Ned Tijdschr Geneeskd. 2005 Apr 16;149(16):855-8. Ned Tijdschr Geneeskd. 2005. PMID: 15868988 Dutch.

8

Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.

Schindhelm RK, Diamant M, Bakker SJ, van Dijk RA, Scheffer PG, Teerlink T, Kostense PJ, Heine RJ. Schindhelm RK, et al. Among authors: diamant m. Eur J Clin Invest. 2005 Jun;35(6):369-74. doi: 10.1111/j.1365-2362.2005.01502.x. Eur J Clin Invest. 2005. PMID: 15948897

9

[Diabetes mellitus: simple classification and corresponding treatment].

Simsek S, Diamant M, Eekhoffen EM, Heine RJ. Simsek S, et al. Among authors: diamant m. Ned Tijdschr Geneeskd. 2006 May 6;150(18):1007-12. Ned Tijdschr Geneeskd. 2006. PMID: 16715862 Review. Dutch.

10

[Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].

Diamant M, Bunck MC, Heine RJ. Diamant M, et al. Ned Tijdschr Geneeskd. 2004 Sep 25;148(39):1912-7. Ned Tijdschr Geneeskd. 2004. PMID: 15495988 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

416 results

Search Page